<?xml version="1.0" ?>
<text author="Elise Berthel, Mélanie  L. Ferlazzo, Clément Devic, Michel Bourguignon, Nicolas Foray" dateCollected="2019-11-03" id="autogum_academic_doc487" shortTile="history-research" sourceURL="https://www.mdpi.com/1422-0067/20/21/5339/htm" speakerCount="0" speakerList="none" title="What Does the History of Research on the Repair of DNA Double-Strand Breaks Tell Us? — A Comprehensive Review of Human Radiosensitivity" type="academic">
<head>
<s type="frag">
6.	LS	@ord@
</s>
<s type="wh">
What	WP	What
do	VBP	do
the	DT	the
Clinical	NNP	Clinical
Data	NNP	Data
Teach	NNP	teach
Us	PRP	us
?	.	?
</s>
</head>
<p>
<s type="decl">
As	IN	as
discussed	VBN	discuss
above	IN	above
,	,	,
the	DT	the
great	JJ	great
majority	NN	majority
of	IN	of
the	DT	the
radiobiological	JJ	radiobiological
investigations	NNS	investigation
have	VBP	have
been	VBN	be
done	VBN	do
with	IN	with
very	RB	very
radioresistant	JJ	radioresistant
and	CC	and
hyper-radiosensitive	JJ	hyper-radiosensitive
cells	NNS	cell
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
hyper-radiosensitive	JJ	hyper-radiosensitive
and	CC	and
hyper-radioresistant	JJ	hyper-radioresistant
cellular	NN	cellular
models	NNS	model
are	VBP	be
not	RB	not
representative	JJ	representative
of	IN	of
the	DT	the
clinical	JJ	clinical
reality	NN	reality
.	.	.
</s>
<s type="decl">
For	IN	for
example	NN	example
,	,	,
there	EX	there
is	VBZ	be
no	DT	no
known	VBN	know
human	JJ	human
genetic	JJ	genetic
syndromes	NNS	syndrome
caused	VBN	cause
by	IN	by
mutations	NNS	mutation
of	IN	of
Ku	NNP	Ku
or	CC	or
DNA-PKcs	NNP	dNA-PKcs
proteins	NNS	protein
,	,	,
the	DT	the
major	JJ	major
NHEJ	NNP	NHEJ
actors	NNS	actor
.	.	.
</s>
<s type="decl">
The	DT	the
only	JJ	only
human	JJ	human
case	NN	case
of	IN	of
gross	JJ	gross
defect	NN	defect
in	IN	in
NHEJ	NNP	NHEJ
function	NN	function
to	TO	to
non-viability	JJ	non-viability
was	VBD	be
caused	VBN	cause
by	IN	by
mutations	NNS	mutation
of	IN	of
DNA	NNP	NN
ligase	SYM	ligase
IV	NNP	IV
(	-LRB-	(
LIG4	NNP	LIG4
)	-RRB-	)
.	.	.
</s>
<s type="decl">
The	DT	the
majority	NN	majority
of	IN	of
cases	NNS	case
of	IN	of
fatal	JJ	fatal
post-radiotherapy	NN	post-radiotherapy
events	NNS	event
were	VBD	be
encountered	VBN	encounter
after	IN	after
whole-body	JJ	whole-body
irradiation	NN	irradiation
of	IN	of
children	NNS	child
with	IN	with
ataxia	JJ	ataxia
telangiectasia	NN	telangiectasia
(	-LRB-	(
AT	IN	AT
)	-RRB-	)
caused	VBN	cause
by	IN	by
homozygous	NN	homozygous
<hi rend="italic">
ATM	NNP	ATM
</hi>
mutations	NNS	mutation
during	IN	during
their	PRP$	their
anti-leukemia	NN	anti-leukemia
or	CC	or
lymphoma	NN	lymphoma
treatment	NN	treatment
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
important	JJ	important
to	TO	to
note	VB	note
that	IN	that
AT	IN	AT
frequency	NN	frequency
is	VBZ	be
of	IN	of
about	RB	about
1/100,000	CD	@card@
.	.	.
</s>
<s type="decl">
By	IN	by
contrast	NN	contrast
,	,	,
about	RB	about
5	CD	5
%	NN	%
–	TO	–
20	CD	@card@
%	NN	%
cancer	NN	cancer
of	IN	of
patients	NNS	patient
treated	VBN	treat
by	IN	by
radiotherapy	NN	radiotherapy
exhibit	NN	exhibit
post-radiotherapy	JJ	post-radiotherapy
tissue	NN	tissue
reactions	NNS	reaction
that	WDT	that
can	MD	can
be	VB	be
considered	VBN	consider
as	IN	as
moderate	JJ	moderate
radiosensitivity	NN	radiosensitivity
.	.	.
</s>
<s type="decl">
Surprisingly	RB	surprisingly
,	,	,
no	DT	no
or	CC	or
very	RB	very
few	JJ	few
rodent	NN	rodent
cells	NNS	cell
with	IN	with
moderate	JJ	moderate
radiosensitivity	NN	radiosensitivity
have	VBP	have
been	VBN	be
the	DT	the
subject	NN	subject
of	IN	of
a	DT	a
published	VBN	publish
radiobiological	JJ	radiobiological
characterization	NN	characterization
.	.	.
</s>
<s type="decl">
Interestingly	RB	Interestingly
,	,	,
some	DT	some
of	IN	of
the	DT	the
proteins	NNS	protein
whose	WP$	whose
mutations	NNS	mutation
are	VBP	be
responsible	JJ	responsible
for	IN	for
these	DT	these
syndromes	NNS	syndrome
were	VBD	be
cited	VBN	cite
as	IN	as
components	NNS	component
of	IN	of
the	DT	the
different	JJ	different
variants	NNS	variant
of	IN	of
A-NHEJ	NNP	A-NHEJ
(	-LRB-	(
see	VB	see
Section	NNP	Section
4	CD	4
)	-RRB-	)
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
some	DT	some
genetic	JJ	genetic
syndromes	NNS	syndrome
,	,	,
associated	VBN	associate
or	CC	or
not	RB	not
with	IN	with
cancer	NN	cancer
proneness	NN	proneness
,	,	,
different	JJ	different
from	IN	from
the	DT	the
precited	JJ	precite
ones	NNS	one
,	,	,
also	RB	also
show	VBP	show
a	DT	a
moderate	JJ	moderate
radiosensitivity	NN	radiosensitivity
:	:	:
this	DT	this
is	VBZ	be
notably	RB	notably
the	DT	the
case	NN	case
of	IN	of
neurofibromatosis	NN	neurofibromatosis
,	,	,
Huntington	NNP	Huntington
’s	POS	's
chorea	NN	chorea
,	,	,
and	CC	and
tuberous	JJ	tuberous
sclerosis	NN	sclerosis
syndromes	NNS	syndrome
.	.	.
</s>
<s type="sub">
It	PRP	it
must	MD	must
be	VB	be
stressed	VBN	stress
that	IN	that
these	DT	these
syndromes	NNS	syndrome
are	VBP	be
caused	VBN	cause
by	IN	by
mutations	NNS	mutation
of	IN	of
cytoplasmic	JJ	cytoplasmic
proteins	NNS	protein
,	,	,
which	WDT	which
may	MD	may
contradict	VB	contradict
the	DT	the
historical	JJ	historical
hypothesis	NN	hypothesis
that	IN	that
nucleus	NN	nucleus
is	VBZ	be
the	DT	the
most	RBS	most
radiosensitive	JJ	radiosensitive
part	NN	part
of	IN	of
the	DT	the
cell	NN	cell
(	-LRB-	(
see	VB	see
the	DT	the
Introduction	NNP	introduction
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
it	PRP	it
also	RB	also
contradicts	VBZ	contradict
the	DT	the
hypothesis	NN	hypothesis
that	IN	that
defect	NN	defect
of	IN	of
DSB	NNP	DSB
repair	NN	repair
is	VBZ	be
the	DT	the
unique	JJ	unique
cause	NN	cause
of	IN	of
cellular	JJ	cellular
radiosensitivity	NN	radiosensitivity
.	.	.
</s>
<s type="decl">
The	DT	the
question	NN	question
of	IN	of
how	WRB	how
to	TO	to
build	VB	build
a	DT	a
unified	JJ	unify
model	NN	model
that	WDT	that
would	MD	would
describe	VB	describe
both	DT	both
hyper-radiosensitivity	NN	hyper-radiosensitivity
observed	VBN	observe
in	IN	in
<hi rend="italic">
LIG4	NNP	LIG4
</hi>
-	:	-
and	CC	and
<hi rend="italic">
ATM	NNP	ATM
</hi>
-mutated	VBN	-mutate
cells	NNS	cell
and	CC	and
moderate	JJ	moderate
radiosensitivity	NN	radiosensitivity
caused	VBN	cause
by	IN	by
impairment	NN	impairment
of	IN	of
alternative	JJ	alternative
signaling	NN	signal
and	CC	and
DSB	NNP	DSB
repair	NN	repair
pathways	NNS	pathway
remains	VBZ	remain
.	.	.
</s>
</p>
<p>
<s type="decl">
To	TO	To
date	NN	date
,	,	,
the	DT	the
ATM	NNP	ATM
protein	NN	protein
has	VBZ	have
been	VBN	be
considered	VBN	consider
as	IN	as
an	DT	an
early	JJ	early
actor	NN	actor
of	IN	of
the	DT	the
DSB	NNP	DSB
recognition	NN	recognition
via	IN	via
its	PRP$	its
phosphorylation	NN	phosphorylation
of	IN	of
H2AX	NNP	H2AX
and	CC	and
the	DT	the
individual	JJ	individual
radiation	NN	radiation
response	NN	response
.	.	.
</s>
<s type="decl">
Surprisingly	RB	surprisingly
,	,	,
ATM	NNP	ATM
has	VBZ	have
not	RB	not
been	VBN	be
integrated	VBN	integrate
in	IN	in
all	PDT	all
the	DT	the
DSB	NNP	DSB
repair	NN	repair
models	NNS	model
discussed	VBN	discuss
above	IN	above
while	IN	while
mutations	NNS	mutation
of	IN	of
RAD51	NNP	RAD51
and	CC	and
RAD52	NNP	RAD52
(	-LRB-	(
for	IN	for
HR	NNP	HR
)	-RRB-	)
and	CC	and
Ku	NNP	Ku
and	CC	and
DNA-PKcs	NNP	dNA-PKcs
(	-LRB-	(
for	IN	for
NHEJ	NNP	NHEJ
)	-RRB-	)
do	VBP	do
not	RB	not
cause	VB	cause
any	DT	any
viable	JJ	viable
syndromes	NNS	syndrome
in	IN	in
humans	NNS	human
(	-LRB-	(
</s>
<figure>
<s type="frag">
Figure	NN	Figure
1	CD	1
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Recently	RB	recently
,	,	,
the	DT	the
delay	NN	delay
in	IN	in
the	DT	the
radiation-induced	JJ	radiation-induced
nucleo-shuttling	NN	nucleo-shuttling
of	IN	of
ATM	NNP	ATM
protein	NN	protein
(	-LRB-	(
RIANS	NNP	RIANS
)	-RRB-	)
was	VBD	be
shown	VBN	show
to	TO	to
be	VB	be
a	DT	a
reliable	JJ	reliable
parameter	NN	parameter
for	IN	for
predicting	VBG	predict
radiosensitivity	NN	radiosensitivity
and	CC	and
to	TO	to
provide	VB	provide
a	DT	a
biologically	RB	biologically
relevant	JJ	relevant
interpretation	NN	interpretation
of	IN	of
the	DT	the
linear-quadratic	JJ	linear-quadratic
model	NN	model
,	,	,
the	DT	the
mathematical	JJ	mathematical
basis	NN	basis
of	IN	of
the	DT	the
cellular	JJ	cellular
radiation	NN	radiation
response	NN	response
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
context	NN	context
of	IN	of
the	DT	the
RIANS	NNP	RIANS
model	NN	model
,	,	,
the	DT	the
following	VBG	follow
mechanistic	JJ	mechanistic
hypothesis	NN	hypothesis
has	VBZ	have
been	VBN	be
proposed	VBN	propose
:	:	:
after	IN	after
irradiation	NN	irradiation
,	,	,
cytoplasmic	JJ	cytoplasmic
trans-auto-phosphorylated	JJ	trans-auto-phosphorylated
dimeric	NN	dimeric
forms	NNS	form
of	IN	of
ATM	NNP	ATM
become	VBN	become
monomeric	JJ	monomeric
and	CC	and
diffuse	JJ	diffuse
to	TO	to
the	DT	the
nucleus	NN	nucleus
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
nucleus	JJ	nucleus
,	,	,
active	JJ	active
ATM	NN	ATM
monomers	NNS	monomer
phosphorylate	VBP	phosphorylate
H2AX	NNP	H2AX
molecules	NNS	molecule
at	IN	at
DSB	NNP	DSB
sites	NNS	site
,	,	,
which	WDT	which
activates	VBZ	activate
NHEJ	NNP	NHEJ
.	.	.
</s>
<s type="decl">
The	DT	the
ATM	NNP	ATM
monomers	NNS	monomer
will	MD	will
re-dimerize	VB	re-dimerize
during	IN	during
the	DT	the
DSB	NNP	DSB
repair	NN	repair
process	NN	process
.	.	.
</s>
<s type="decl">
Once	RB	once
in	IN	in
nucleus	NN	nucleus
,	,	,
ATM	NN	ATM
may	MD	may
also	RB	also
inhibit	VB	inhibit
MRE11	NNP	Mre
nuclease	NN	nuclease
activity	NN	activity
or	CC	or
any	DT	any
other	JJ	other
actor	NN	actor
responsible	JJ	responsible
for	IN	for
genomic	JJ	genomic
instability	NN	instability
.	.	.
</s>
<s type="sub">
By	IN	by
contrast	NN	contrast
,	,	,
in	IN	in
cells	NNS	cell
with	IN	with
moderate	JJ	moderate
radiosensitivity	NN	radiosensitivity
,	,	,
over-expressed	VBN	over-expressed
ATM	NN	ATM
substrates	NNS	substrate
may	MD	may
delay	VB	delay
the	DT	the
RIANS	NNP	RIANS
,	,	,
thereby	RB	thereby
favoring	VBG	favor
cancer	NN	cancer
proneness	NN	proneness
and	CC	and
aging	NN	aging
.	.	.
</s>
<s type="decl">
This	DT	this
is	VBZ	be
notably	RB	notably
the	DT	the
case	NN	case
for	IN	for
huntingtin	NN	huntingtin
,	,	,
neurofibromin	NN	neurofibromin
,	,	,
and	CC	and
tuberin	NN	tuberin
.	.	.
</s>
<s type="frag">
(	-LRB-	(
</s>
<figure>
<s type="frag">
Figure	NN	Figure
6	CD	6
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
</p>
<p>
<s type="decl">
Three	CD	Three
groups	NNS	group
of	IN	of
radiosensitivity	NN	radiosensitivity
have	VBP	have
been	VBN	be
defined	VBN	define
:	:	:
</s>
</p>
<p>
<s type="decl">
Group	NN	Group
I	PRP	I
(	-LRB-	(
about	RB	about
75	CD	@card@
%	NN	%
to	TO	to
85	CD	@card@
%	NN	%
whole	JJ	whole
population	NN	population
)	-RRB-	)
represents	VBZ	represent
the	DT	the
normosensitive	NN	normosensitive
(	-LRB-	(
radioresistant	JJ	radioresistant
)	-RRB-	)
patients	NNS	patient
with	IN	with
a	DT	a
rapid	JJ	rapid
RIANS	NN	RIANS
after	IN	after
2	CD	2
Gy	NNP	gy
,	,	,
a	DT	a
low	JJ	low
risk	NN	risk
of	IN	of
post-radiotherapy	JJ	post-radiotherapy
tissue	NN	tissue
reaction	NN	reaction
and	CC	and
of	IN	of
cancer	NN	cancer
</s>
</p>
<p>
<s type="decl">
Group	NN	Group
II	NNP	II
(	-LRB-	(
about	RB	about
5	CD	5
–	TO	–
20	CD	@card@
%	NN	%
of	IN	of
whole	JJ	whole
population	NN	population
)	-RRB-	)
represents	VBZ	represent
the	DT	the
patients	NNS	patient
who	WP	who
elicit	VBP	elicit
a	DT	a
moderate	JJ	moderate
radiosensitivity	NN	radiosensitivity
with	IN	with
a	DT	a
delay	NN	delay
in	IN	in
the	DT	the
RIANS	NNPS	RIANS
due	JJ	due
to	TO	to
the	DT	the
sequestration	NN	sequestration
of	IN	of
ATM	NNP	ATM
by	IN	by
mutated	VBN	mutate
and	CC	and
over-expressed	VBN	over-expressed
substrates	NNS	substrate
.	.	.
</s>
<s type="decl">
These	DT	these
patients	NNS	patient
are	VBP	be
moderately	RB	moderately
radiosensitive	JJ	radiosensitive
and	CC	and
may	MD	may
have	VB	have
a	DT	a
high	JJ	high
risk	NN	risk
of	IN	of
cancer	NN	cancer
or	CC	or
neurodegeneration	NN	neurodegeneration
.	.	.
</s>
</p>
<p>
<s type="decl">
Group	NN	Group
III	NNP	III
(	-LRB-	(
<1	CD	<1
%	NN	%
whole	JJ	whole
population	NN	population
)	-RRB-	)
represents	VBZ	represent
the	DT	the
<hi rend="italic">
ATM	NNP	ATM
</hi>
-mutated	VBN	-mutate
patients	NNS	patient
with	IN	with
no	DT	no
functional	JJ	functional
ATM	NN	ATM
kinase	NN	kinase
or	CC	or
those	DT	those
who	WP	who
show	VBP	show
strong	JJ	strong
DSB	NNP	DSB
repair	NN	repair
defects	NNS	defect
(	-LRB-	(
like	IN	like
the	DT	the
<hi rend="italic">
LIG4	NNP	LIG4
</hi>
-mutated	VBN	-mutate
patient	NN	patient
described	VBN	describe
above	IN	above
)	-RRB-	)
,	,	,
hyper-radiosensitivity	NN	hyper-radiosensitivity
,	,	,
and	CC	and
either	DT	either
high	JJ	high
cancer	NN	cancer
proneness	NN	proneness
or	CC	or
severe	JJ	severe
accelerated	VBN	accelerate
aging	NN	aging
.	.	.
</s>
</p>
<p>
<s type="decl">
While	IN	while
it	PRP	it
provides	VBZ	provide
relevant	JJ	relevant
explanation	NN	explanation
of	IN	of
the	DT	the
radiosensitivity	NN	radiosensitivity
of	IN	of
syndromes	NNS	syndrome
caused	VBN	cause
by	IN	by
mutations	NNS	mutation
of	IN	of
cytoplasmic	JJ	cytoplasmic
proteins	NNS	protein
,	,	,
the	DT	the
RIANS	NNP	RIANS
model	NN	model
appears	VBZ	appear
to	TO	to
be	VB	be
compatible	JJ	compatible
with	IN	with
all	PDT	all
the	DT	the
alternative	JJ	alternative
models	NNS	model
,	,	,
as	IN	as
ATM	NNP	ATM
is	VBZ	be
upstream	NN	upstream
of	IN	of
all	PDT	all
the	DT	the
cascades	NNS	cascade
of	IN	of
radiation-induced	JJ	radiation-induced
phosphorylations	NNS	phosphorylation
involved	VBN	involve
in	IN	in
the	DT	the
individual	JJ	individual
response	NN	response
to	TO	to
IR	NNP	IR
.	.	.
</s>
<s type="decl">
Obviously	RB	obviously
,	,	,
further	JJR	further
investigations	NNS	investigation
are	VBP	be
needed	VBN	need
to	TO	to
better	JJR	good
understand	VB	understand
the	DT	the
direct	JJ	direct
or	CC	or
indirect	JJ	indirect
role	NN	role
of	IN	of
cytoplasmic	JJ	cytoplasmic
ATM	NNP	ATM
forms	NNS	form
in	IN	in
the	DT	the
activation	NN	activation
or	CC	or
the	DT	the
inhibition	NN	inhibition
of	IN	of
DSB	NNP	DSB
repair	NN	repair
pathways	NNS	pathway
.	.	.
</s>
</p>
</text>
